Furthermore, COVID-19-related changes in ncRNAs and transcription factors reflect increased risks of developing lung inflammation and cholinergic neurons demise [54], and elevated risk of severe COVID-19 was linked to the genetic OAS1 variant that associates with elevated risk of AD [127]. This evidence concerns the gene OAS1 and Alzheimer disease.